EMPULSE Trademark

Trademark Overview

On Tuesday, August 20, 2019, a trademark application was filed for EMPULSE with the United States Patent and Trademark Office. The USPTO has given the EMPULSE trademark a serial number of 79271196. The federal status of this trademark filing is REGISTERED as of Tuesday, May 12, 2020. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPULSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes and cardiovascular diseases; providing medical and scientific research information in the field of diabetes and cardiovascular diseases
empulse

General Information

Serial Number79271196
Word MarkEMPULSE
Filing DateTuesday, August 20, 2019
Status700 - REGISTERED
Status DateTuesday, May 12, 2020
Registration Number6050404
Registration DateTuesday, May 12, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesMedical and scientific research in the field of diabetes and cardiovascular diseases; providing medical and scientific research information in the field of diabetes and cardiovascular diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 13, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Sunday, October 11, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 18, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 18, 2020FINAL DISPOSITION PROCESSED
Wednesday, August 12, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 12, 2020REGISTERED-PRINCIPAL REGISTER
Sunday, March 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 22, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, March 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Saturday, February 22, 2020NOTIFICATION PROCESSED BY IB
Wednesday, February 5, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 5, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020ASSIGNED TO LIE
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 10, 2020REFUSAL PROCESSED BY IB
Friday, December 20, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 20, 2019REFUSAL PROCESSED BY MPU
Saturday, November 23, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 22, 2019NON-FINAL ACTION WRITTEN
Tuesday, November 19, 2019ASSIGNED TO EXAMINER
Tuesday, November 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, November 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

empulse cardiovascular diseases medical diabetes field scientific research information providing